24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Securities
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:44
Tel Aviv Stock Exchange CEO offered $1.65 million retention package as his stake reaches $145 million
21:19
Amdocs server farm was allegedly chosen as target in planned terror attack
20:59
Serbia opens Israeli drone factory as defense ties with Elbit deepen
15:55
Israel won’t force Chevron out of Tamar or Leviathan
More stories
Buzz
Most popular
Daily
Weekly
1
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
2
The man who helped build Palo Alto’s Cortex is leaving the company
3
Serbia opens Israeli drone factory as defense ties with Elbit deepen
4
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
5
Five months old, Noetive raises $41 million Seed to build AI for the physical economy
More news
Securities
2 stories about Securities
Israeli Regulator to Mutual Fund Managers: Don't Invest in Bitcoin Futures
12.12.17
|
Raheli Bindman
Global bitcoin futures opened for trading for the first time this week, sending enthusiasts into an investment frenzy
Allergan Planning Sale of its Teva Stock
01.11.17
|
Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.
Previous Articles